Please login to the form below
The Editors blog
An inside look at what’s happening within the pharma industry and across the PMGroup from the PMLiVE editorial team
Jeux sans frontières
Can NICE deliver on its funding promises?10 Mar 2017
The Institute is now half-way thorugh its Cancer Drugs Fund reappraisals
Brexit: Bad for health, science and pharma15 Jun 2016
Health care voices join the life sciences sector in warning of the negative impact of leaving the EU
Finalists revealed for Communiqué Awards 201609 Jun 2016
Forty-three agencies in the running for one of the prestigious prizes
GSK and Novartis asset swap: a tale of two companies13 Mar 2015
Firms complete multi-billion dollar exchange ofoncology, vaccines and consumer health interests
2014: a year to build pharma's reputation02 Jul 2014
Recent megamerger prospects have led to a backlash in the mainstream media
Burden of proof06 Jun 2014
Breakthroughs in Alzheimer's are sorely needed, but there's still lots of work to do on AD04
A sharper focus16 May 2014
The enthusiasm for massive M&A deals is set to redraw industry boundaries
-
Open season?
17 Feb 2014
The EMA's decision to post minutes of CHMP meetings is another step forward for industry transparency
Resistance's irresistible need14 Jan 2014
Industry's anti-infective efforts step up a gear
Featured jobs
-
Vice President
-
Competitive Salary Offered
-
Principal Medical Writer
-
£48 - 58, 000 according to skills and experience benefits
-
Consultant
-
competitive salary
- Senior Medical Writer, MedComms Agency
-
Salary TBC
- Account Director or Senior Account Director
-
Salary TBC
- Account Manager– Medical Communications
-
(Negotiable - depending on experience)
- Director of Scientific Services, Medical Communications, Six fig...
-
Six figure salary
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
Subscribe to our email news alerts
- New coronavirus sees drug developers scramble to develop a vaccine
- Moving annual total (MAT)
- Novartis links up with NHS for speedy access to cholesterol drug inclisiran
- NICE knocks back AstraZeneca's Tagrisso again
- Immuno-oncology, personalised medicine continues to drive pharma sector
- Roche's checkpoint inhibitor fails pivotal urothelial cancer trial
- Data desires
- TBWA\WorldHealth London announces restructure and key hires
- WHITE PAPER: Marketing fulfilment – a balancing act
- AZ, Daiichi Sankyo’s Enhertu set fair for filing in gastric cancer
- Roche files Tecentriq/Avastin combo in liver cancer
- New coronavirus sees drug developers scramble to develop a vaccine
PMHub
Aptus Health
Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...
Latest intelligence
- Data desires
- What are you looking to achieve with data and how are you preparing yourself to react to the results?...
- The balancing act that’s keeping pharma and biotech market access on its toes
- Pricing drugs and gaining reimbursement can be a real challenge for drug developers. Price it too high, and no one buys it. Price it too low, and it’s hard to...
- Tackling antimicrobial resistance on multiple fronts
- An urgent change of direction is needed in how we respond to AMR...
Quick links
Infographics
